Catalyst Wire Dossier Catalyst Wire Dossier

BI 137882

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 137882, covering 2014-06-04 to 2014-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers [Phase 1]

See pricing